Isd. Roberts et al., INTERSTITIAL MYOFIBROBLASTS - PREDICTORS OF PROGRESSION IN MEMBRANOUSNEPHROPATHY, Journal of Clinical Pathology, 50(2), 1997, pp. 123-127
Aims-To determine the role of interstitial myofibroblasts in the progr
ession of membranous nephropathy; and to assess the predictive value o
f quantifying myofibroblasts in determining long term renal outcome. M
ethods-All cases of membranous nephropathy, diagnosed by renal biopsy
at University Hospital of South Manchester between 1984 and 1987, were
studied retrospectively. The biopsy specimens (n = 26) were reviewed
and analysed morphometrically to measure interstitial volume as a prop
ortion of the total volume of renal cortex, and numbers of interstitia
l myofibroblasts (cells positive for a-smooth muscle actin within the
interstitium). Clinical data, with a follow up of seven to eight years
, was available for 24 patients, and renal outcome was correlated with
pathological changes in the initial diagnostic biopsy specimen. Resul
ts-The number of myofibroblasts and interstitial volume were inversely
correlated with creatinine clearance at the initial biopsy, and at th
e end of follow up. Percentage sclerosed glomeruli or stage of glomeru
lar disease, assessed by electron microscopy, did not correlate with r
enal function at initial biopsy or during follow up. The number of myo
fibroblasts, but not interstitial volume, correlated with severity of
proteinuria at initial biopsy. Of 15 biopsy specimens showing no or mi
ld interstitial fibrosis, four showed a notable increase in the number
of interstitial myofibroblasts. All of these patients developed chron
ic renal failure, compared with three of 11 patients whose specimens s
howed no or a mild increase in myofibroblast numbers. Conclusions-Inte
rstitial myofibroblasts play a role in the development of interstitial
fibrosis and progressive renal failure in membranous nephropathy. Inc
reased numbers of myofibroblasts in biopsy specimens showing only mild
fibrosis may predict subsequent chronic renal failure.